Novo Nordisk to Introduce Ozempic in India This Month
Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) is preparing to roll out its diabetes medication Ozempic in India within the next…
Semaglutide
Read More
Eli Lilly Prepares to Launch Obesity and Diabetes Drug Tirzepatide in India by 2025
Eli Lilly, the U.S.-based pharmaceutical giant, plans to introduce its obesity and diabetes drug Tirzepatide (marketed as Mounjaro) in India…
Semaglutide: Transform Your Health with Powerful Weight Loss and Heart Benefits
Semaglutide: A Dual Benefit for Heart Health and Weight Loss, but Potential Gut Issues Ahead semaglutide has emerged as a…
“Semaglutide Breakthrough: A Promising Solution for Treating Chronic Skin Condition in Obese Patients!”
Semaglutide, a medication initially developed for the treatment of type 2 diabetes and obesity, is now showing promising results in…